Guggulipid use in hyperlipidemia: Case report and review of the literature

American Journal of Health-System Pharmacy

Volumn 62, Issue 16, 2005, Pages 1690-1692

  Sahni, Sona ^a   Hepfinger, Charley A ^a   Sauer, Karen Ann ^a,b  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; GUGGULSTERONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; NICOTINE; PLACEBO; SABAL EXTRACT; SIMVASTATIN;

ADULT; CASE REPORT; CHOLESTEROL BLOOD LEVEL; COMMIPHORA; DIARRHEA; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACIST; PRIORITY JOURNAL; REVIEW; TRADITIONAL MEDICINE;

EID: 23844463495     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp040580     Document Type: Review

References (19)

1. Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther. 1994; 8:659-64.
2. Nagarajan M, Waszkuc TW, Sun J. Simultaneous determination of E- and Z-guggulsterones in dietary supplements containing Commiphora mukul extract (guggulipid) by liquid chromatography. J AOAC Int. 2001; 84:24-8.
3. Szapary PO, Wolfe ML, Bloedon LT et al. Guggulipid for the treatment of hypercholesterolemia, a randomized controlled trial. JAMA. 2003; 290:765-72.
4. Natural Medicines Comprehensive Database. Guggul monograph. www. naturaldatabase.com (accessed 2003 Sep 24).
5. Urizar NL, Liverman AB, Dodds DT et al. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 2002; 296:1703-6.
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.
7. Naranjo CA, Busto U, Sellers EM et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
8. Das Gupta R. A new hypolipidaemic agent (gugulipid). J Assoc Physicians India. 1990; 38:186. Letter.
9. Das Gupta R. Gugulipid: pro-lipaemic effect. J Assoc Physicians India. 1990; 38: 598. Letter.
10. Agarwal RC, Singh SP, Saran SK et al. Clinical trial of gugulipid-a new hypolipidemic agent of plant origin in primary hyperlipidemia. Indian J Med Res. 1986; 84:626-32.
11. Gopal K, Saran RK, Nityanand S et al. Clinical trial of ethyl acetate extract of gum gugulu (gugulipid) in primary hyperlipidemia. J Assoc Physicians India. 1986; 34:249-51.
12. Malhotra SC, Ahuja MMS, Sundaram KR. Long term clinical studies on the hypolipidaemic effect of Commiphora mukul (guggulu) and clofibrate. Indian J Med Res. 1977; 65:390-5.
13. Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid, a new hypolipidaemic agent. J Assoc Physicians India. 1989; 37:323-8.
14. Verma SK, Bordia A. Effect of Commiphora mukul (gum guggulu) in patients of hyperlipidemia with special reference to HDL-cholesterol. Indian J Med Res. 1988; 87:356-60.
15. Kuppurajan K, Rajagopalan SS, Koteswara Rao T et al. Effect of guggulu (Commiphora mukul-Engl.) on serum lipids in obese, hypercholesterolemic and hyperlipemic cases. J Assoc Physicians India. 1978; 26:367-73.
16. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344:1383-9.
17. White HD, Simes RJ, Anderson NE et al. Pravastatin therapy and the risk of stroke. N Engl J Med. 2000; 343:317-26.
18. American Society of Health-System Pharmacists. ASHP therapeutic position statement on the safe use of niacin in the management of dyslipidemias. Am J Health-Syst Pharm. 1997; 54: 2815-9.
19. American Society of Health-System Pharmacists. ASHP statement on the use of dietary supplements. Am J Health-Syst Pharm. 2004; 61:1707-11.